Lipids and prostate cancer

Prostaglandins and Other Lipid Mediators

Volumn 98, Issue 1-2, 2012, Pages 1-10

  Suburu, Janel ^a   Chen, Yong Q ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

De novo lipogenesis; Dietary fat; Prostate cancer

Indexed keywords

FATTY ACID; LIPID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL SYNTHESIS; DIET; FAT INTAKE; FATTY ACID SYNTHESIS; HUMAN; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; PHENOTYPE; PROSTATE CANCER; REVIEW; STEROIDOGENESIS;

ANIMALS; DIETARY FATS; HUMANS; LIPID METABOLISM; LIPOGENESIS; MALE; PROSTATIC NEOPLASMS;

EID: 84860780251     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.03.003     Document Type: Review

References (170)

1. P.D. Baade, D.R. Youlden, and L.J. Krnjacki International epidemiology of prostate cancer: geographical distribution and secular trends Mol Nutr Food Res 53 2 2009 171 184
2. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 4 2011 212 236
3. O. Warburg, F. Wind, and E. Negelein The metabolism of tumors in the body J Gen Physiol 8 6 1927 519 530
4. F.P. Kuhajda, K. Jenner, F.D. Wood, R.A. Hennigar, L.B. Jacobs, and J.D. Dick Fatty acid synthesis: a potential selective target for antineoplastic therapy Proc Natl Acad Sci U S A 91 14 1994 6379 6383 (Pubitemid 24200664)
5. A. Jayakumar, M.H. Tai, W.Y. Huang, W. Al-Feel, M. Hsu, and L. Abu-Elheiga Human fatty acid synthase: properties and molecular cloning Proc Natl Acad Sci U S A 92 19 1995 8695 8699
6. C.F. Semenkovich, T. Coleman, and F.T. Fiedorek Jr. Human fatty acid synthase mRNA: tissue distribution, genetic mapping, and kinetics of decay after glucose deprivation J Lipid Res 36 7 1995 1507 1521
7. G. Medes, A. Thomas, and S. Weinhouse Metabolism of neoplastic tissue IV. A study of lipid synthesis in neoplastic tissue slices in vitro Cancer Res 13 1 1953 27 29
8. U.S. Shah, R. Dhir, S.M. Gollin, U.R. Chandran, D. Lewis, and M. Acquafondata Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma Hum Pathol 37 4 2006 401 409
9. J.V. Swinnen, H. Heemers, L. Deboel, F. Foufelle, W. Heyns, and G. Verhoeven Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway Oncogene 19 45 2000 5173 5181
10. J.V. Swinnen, M. Esquenet, K. Goossens, W. Heyns, and G. Verhoeven Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP Cancer Res 57 6 1997 1086 1090 (Pubitemid 27138606)
11. J.V. Swinnen, F. Vanderhoydonc, A.A. Elgamal, M. Eelen, I. Vercaeren, and S. Joniau Selective activation of the fatty acid synthesis pathway in human prostate cancer Int J Cancer 88 2 2000 176 179
12. J.V. Swinnen, T. Roskams, S. Joniau, H. Van Poppel, R. Oyen, and L. Baert Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer Int J Cancer 98 1 2002 19 22 (Pubitemid 34113412)
13. E. Graner, D. Tang, S. Rossi, A. Baron, T. Migita, and L.J. Weinstein The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer Cancer Cell 5 3 2004 253 261 (Pubitemid 38402117)
14. S. Wang, J. Gao, Q. Lei, N. Rozengurt, C. Pritchard, and J. Jiao Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Cancer Cell 4 3 2003 209 221 (Pubitemid 37163835)
15. H.B. Pearson, A. McCarthy, C.M. Collins, A. Ashworth, and A.R. Clarke Lkb1 deficiency causes prostate neoplasia in the mouse Cancer Res 68 7 2008 2223 2232 (Pubitemid 351521795)
16. T. Van de Sande, T. Roskams, E. Lerut, S. Joniau, H. Van Poppel, and G. Verhoeven High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB J Pathol 206 2 2005 214 219 (Pubitemid 40754025)
17. T. Migita, S. Ruiz, A. Fornari, M. Fiorentino, C. Priolo, and G. Zadra Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer J Natl Cancer Inst 101 7 2009 519 532
18. G. Liang, J. Yang, J.D. Horton, R.E. Hammer, J.L. Goldstein, and M.S. Brown Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c J Biol Chem 277 11 2002 9520 9528 (Pubitemid 34953041)
19. W.C. Huang, X. Li, J. Liu, J. Lin, and L.W. Chung Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells Mol Cancer Res 10 1 2012 133 142
20. L.Z. Milgraum, L.A. Witters, G.R. Pasternack, and F.P. Kuhajda Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma Clin Cancer Res 3 11 1997 2115 2120 (Pubitemid 27505140)
21. T.S. Gansler, W. Hardman 3rd, D.A. Hunt, S. Schaffel, and R.A. Hennigar Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival Hum Pathol 28 6 1997 686 692 (Pubitemid 27258421)
22. A. Rashid, E.S. Pizer, M. Moga, L.Z. Milgraum, M. Zahurak, and G.R. Pasternack Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia Am J Pathol 150 1 1997 201 208 (Pubitemid 27027110)
23. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 7 10 2007 763 777 (Pubitemid 47469806)
24. F.P. Kuhajda Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology Nutrition 16 3 2000 202 208 (Pubitemid 30114274)
25. J.V. Swinnen, K. Brusselmans, and G. Verhoeven Increased lipogenesis in cancer cells: new players, novel targets Curr Opin Clin Nutr Metab Care 9 4 2006 358 365 (Pubitemid 44101970)
26. V. Fritz, Z. Benfodda, G. Rodier, C. Henriquet, F. Iborra, and C. Avances Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice Mol Cancer Ther 9 6 2010 1740 1754
27. G. Hatzivassiliou, F. Zhao, D.E. Bauer, C. Andreadis, A.N. Shaw, and D. Dhanak ATP citrate lyase inhibition can suppress tumor cell growth Cancer Cell 8 4 2005 311 321 (Pubitemid 41443416)
28. S.J. Kridel, F. Axelrod, N. Rozenkrantz, and J.W. Smith Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity Cancer Res 64 6 2004 2070 2075 (Pubitemid 38339455)
29. K. Brusselmans, E. De Schrijver, G. Verhoeven, and J.V. Swinnen RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells Cancer Res 65 15 2005 6719 6725 (Pubitemid 41060709)
30. E. De Schrijver, K. Brusselmans, W. Heyns, G. Verhoeven, and J.V. Swinnen RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells Cancer Res 63 13 2003 3799 3804 (Pubitemid 36793069)
31. A. Beckers, S. Organe, L. Timmermans, K. Scheys, A. Peeters, and K. Brusselmans Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells Cancer Res 67 17 2007 8180 8187 (Pubitemid 47395154)
32. J.V. Swinnen, P.P. Van Veldhoven, L. Timmermans, E. De Schrijver, K. Brusselmans, and F. Vanderhoydonc Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains Biochem Biophys Res Commun 302 4 2003 898 903 (Pubitemid 36294061)
33. H. Zheng, W. Liu, L.Y. Anderson, and Q.X. Jiang Lipid-dependent gating of a voltage-gated potassium channel Nat Commun 2 2011 250
34. P.M. Alli, M.L. Pinn, E.M. Jaffee, J.M. McFadden, and F.P. Kuhajda Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice Oncogene 24 1 2005 39 46 (Pubitemid 40143863)
35. E. Rysman, K. Brusselmans, K. Scheys, L. Timmermans, R. Derua, and S. Munck De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation Cancer Res 70 20 2011 8117 8126
36. M. Fiorentino, G. Zadra, E. Palescandolo, G. Fedele, D. Bailey, and C. Fiore Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer Lab Invest 88 12 2008 1340 1348
37. M.V. Chakravarthy, I.J. Lodhi, L. Yin, R.R. Malapaka, H.E. Xu, and J. Turk Identification of a physiologically relevant endogenous ligand for PPARalpha in liver Cell 138 3 2009 476 488
38. W. Zhou, P.J. Simpson, J.M. McFadden, C.A. Townsend, S.M. Medghalchi, and A. Vadlamudi Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells Cancer Res 63 21 2003 7330 7337 (Pubitemid 37413474)
39. J.E. Wilson Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function J Exp Biol 206 Pt 12 2003 2049 2057 (Pubitemid 36761808)
40. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria Oncogene 25 34 2006 4777 4786 (Pubitemid 44187625)
41. J.S. Moon, W.J. Jin, J.H. Kwak, H.J. Kim, M.J. Yun, and J.W. Kim Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells Biochem J 433 1 2011 225 233
42. S. Mazurek, C.B. Boschek, F. Hugo, and E. Eigenbrodt Pyruvate kinase type M2 and its role in tumor growth and spreading Semin Cancer Biol 15 4 2005 300 308 (Pubitemid 41058775)
43. E. Eigenbrodt, M. Reinacher, U. Scheefers-Borchel, H. Scheefers, and R. Friis Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells Crit Rev Oncog 3 1-2 1992 91 115
44. H.R. Christofk, M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, and R. Wei The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 7184 2008 230 233 (Pubitemid 351380249)
45. D. Anastasiou, G. Poulogiannis, J.M. Asara, M.B. Boxer, J.K. Jiang, and M. Shen Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses Science 334 6060 2011 1278 1283
46. M.G. Vander Heiden, J.W. Locasale, K.D. Swanson, H. Sharfi, G.J. Heffron, and D. Amador-Noguez Evidence for an alternative glycolytic pathway in rapidly proliferating cells Science 329 5998 2010 1492 1499
47. H.J. Koh, S.M. Lee, B.G. Son, S.H. Lee, Z.Y. Ryoo, and K.T. Chang Cytosolic NADP+-dependent isocitrate dehydrogenase plays a key role in lipid metabolism J Biol Chem 279 38 2004 39968 39974 (Pubitemid 39258270)
48. Z.J. Reitman, and H. Yan Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism J Natl Cancer Inst 102 13 2010 932 941
49. A.K. Murugan, E. Bojdani, and M. Xing Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer Biochem Biophys Res Commun 393 3 2010 555 559
50. M.E. Mycielska, A. Patel, N. Rizaner, M.P. Mazurek, H. Keun, and V. Ganapathy Citrate transport and metabolism in mammalian cells: prostate epithelial cells and prostate cancer Bioessays 31 1 2009 10 20
51. J.P. Kavanagh Isocitric and citric acid in human prostatic and seminal fluid: implications for prostatic metabolism and secretion Prostate 24 3 1994 139 142 (Pubitemid 24109594)
52. A. Medrano, J.M. Fernandez-Novell, L. Ramio, J. Alvarez, E. Goldberg, and M. Montserrat Rivera Utilization of citrate and lactate through a lactate dehydrogenase and ATP-regulated pathway in boar spermatozoa Mol Reprod Dev 73 3 2006 369 378 (Pubitemid 43262052)
53. M.E. Mycielska, T.P. Broke-Smith, C.P. Palmer, R. Beckerman, T. Nastos, and K. Erguler Citrate enhances in vitro metastatic behaviours of PC-3M human prostate cancer cells: status of endogenous citrate and dependence on aconitase and fatty acid synthase Int J Biochem Cell Biol 38 10 2006 1766 1777 (Pubitemid 44173018)
54. R.J. DeBerardinis, A. Mancuso, E. Daikhin, I. Nissim, M. Yudkoff, and S. Wehrli Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proc Natl Acad Sci U S A 104 49 2007 19345 19350
55. X. Liu, Y.M. Fu, and G.G. Meadows Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells Oncol Lett 2 2 2011 349 355
56. A.R. Mullen, W.W. Wheaton, E.S. Jin, P.H. Chen, L.B. Sullivan, and T. Cheng Reductive carboxylation supports growth in tumour cells with defective mitochondria Nature 481 7381 2012 385 388
57. C.M. Metallo, P.A. Gameiro, E.L. Bell, K.R. Mattaini, J. Yang, and K. Hiller Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia Nature 481 7381 2012 380 384
58. B.D. Manning, and L.C. Cantley AKT/PKB signaling: navigating downstream Cell 129 7 2007 1261 1274 (Pubitemid 46962095)
59. I.C. Gray, L.M. Stewart, S.M. Phillips, J.A. Hamilton, N.E. Gray, and G.J. Watson Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN Br J Cancer 78 10 1998 1296 1300 (Pubitemid 28495240)
60. Y. Li, J. Su, X. DingZhang, J. Zhang, M. Yoshimoto, and S. Liu PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome J Pathol 224 1 2011 90 100
61. T.W. Friedlander, R. Roy, S.A. Tomlins, V.T. Ngo, Y. Kobayashi, and A. Azameera Common structural and epigenetic changes in the genome of castration-resistant prostate cancer Cancer Res 72 3 2012 616 625
62. N. Chalhoub, and S.J. Baker PTEN and the PI3-kinase pathway in cancer Annu Rev Pathol 4 2009 127 150
63. T. Van de Sande, E. De Schrijver, W. Heyns, G. Verhoeven, and J.V. Swinnen Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells Cancer Res 62 3 2002 642 646 (Pubitemid 34126933)
64. H.Q. Wang, D.A. Altomare, K.L. Skele, P.I. Poulikakos, F.P. Kuhajda, and A. Di Cristofano Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells Oncogene 24 22 2005 3574 3582 (Pubitemid 40756227)
65. K. Tomek, R. Wagner, F. Varga, C.F. Singer, H. Karlic, and T.W. Grunt Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer Mol Cancer Res 9 12 2011 1767 1779
66. M.J. Higgins, and J. Baselga Targeted therapies for breast cancer J Clin Invest 121 10 2011 3797 3803
67. S. Minner, B. Jessen, L. Stiedenroth, E. Burandt, J. Kollermann, and M. Mirlacher Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer Clin Cancer Res 16 5 2010 1553 1560
68. C. Kumar-Sinha, K.W. Ignatoski, M.E. Lippman, S.P. Ethier, and A.M. Chinnaiyan Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis Cancer Res 63 1 2003 132 139 (Pubitemid 36070431)
69. S. Yoon, M.Y. Lee, S.W. Park, J.S. Moon, Y.K. Koh, and Y.H. Ahn Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells J Biol Chem 282 36 2007 26122 26131 (Pubitemid 47443806)
70. B. Kumar, S. Koul, L. Khandrika, R.B. Meacham, and H.K. Koul Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype Cancer Res 68 6 2008 1777 1785 (Pubitemid 351416563)
71. M. Shiota, A. Yokomizo, Y. Tada, J. Inokuchi, E. Kashiwagi, and D. Masubuchi Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression Oncogene 29 2 2010 237 250
72. M. Shiota, A. Yokomizo, and S. Naito Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer Free Radic Biol Med 51 7 2011 1320 1328
73. J.S. Clerkin, R. Naughton, C. Quiney, and T.G. Cotter Mechanisms of ROS modulated cell survival during carcinogenesis Cancer Lett 266 1 2008 30 36
74. E. Furuta, S.K. Pai, R. Zhan, S. Bandyopadhyay, M. Watabe, and Y.Y. Mo Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1 Cancer Res 68 4 2008 1003 1011 (Pubitemid 351278386)
75. S.S. Brar, Z. Corbin, T.P. Kennedy, R. Hemendinger, L. Thornton, and B. Bommarius NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells Am J Physiol Cell Physiol 285 2 2003 C353 C369
76. W.C. Huang, H.E. Zhau, and L.W. Chung Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells J Biol Chem 285 11 2010 7947 7956
77. X. Yang, Z. Guo, F. Sun, W. Li, A. Alfano, and H. Shimelis Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells J Biol Chem 286 41 2011 36152 36160
78. S.J. Kim, H. Choi, S.S. Park, C. Chang, and E. Kim Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation Mol Cells 31 4 2011 371 377
79. N.V. Guseva, O.W. Rokhlin, R.A. Glover, and M.B. Cohen TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status Cancer Biol Ther 12 1 2011 80 85
80. D. Eberle, B. Hegarty, P. Bossard, P. Ferre, and F. Foufelle SREBP transcription factors: master regulators of lipid homeostasis Biochimie 86 11 2004 839 848 (Pubitemid 39602764)
81. S.L. Ettinger, R. Sobel, T.G. Whitmore, M. Akbari, D.R. Bradley, and M.E. Gleave Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence Cancer Res 64 6 2004 2212 2221 (Pubitemid 38339475)
82. Y. Chen, and M. Hughes-Fulford Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2 Int J Cancer 91 1 2001 41 45
83. M.R. Freeman, and K.R. Solomon Cholesterol and prostate cancer J Cell Biochem 91 1 2004 54 69
84. M.H. Hager, K.R. Solomon, and M.R. Freeman The role of cholesterol in prostate cancer Curr Opin Clin Nutr Metab Care 9 4 2006 379 385 (Pubitemid 44097806)
85. D.M. Boudreau, O. Yu, and J. Johnson Statin use and cancer risk: a comprehensive review Expert Opin Drug Saf 9 4 2010 603 621
86. J. Shannon, S. Tewoderos, M. Garzotto, T.M. Beer, R. Derenick, and A. Palma Statins and prostate cancer risk: a case-control study Am J Epidemiol 162 4 2005 318 325 (Pubitemid 41389713)
87. K.R. Solomon, and M.R. Freeman Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19 4 2008 113 121 (Pubitemid 351608305)
88. M. Roy, H.J. Kung, and P.M. Ghosh Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins Am J Cancer Res 1 4 2011 542 561
89. D.J. Mener Prostate specific antigen reduction following statin therapy: mechanism of action and review of the literature IUBMB Life 62 8 2010 584 590
90. Clendening JW, Penn LZ. Targeting tumor cell metabolism with statins. Oncogene advanced online publication, 6 February 2012; doi:10.1038/onc.2012.6, PMID: 22310279.
91. V.K. Grover, J.G. Valadez, A.B. Bowman, and M.K. Cooper Lipid modifications of Sonic hedgehog ligand dictate cellular reception and signal response PLoS ONE 6 7 2011 e21353
92. J.M. Bailey, P.K. Singh, and M.A. Hollingsworth Cancer metastasis facilitated by developmental pathways: sonic hedgehog, Notch, and bone morphogenic proteins J Cell Biochem 102 4 2007 829 839 (Pubitemid 350036923)
93. S. Staubach, and F.G. Hanisch Lipid rafts: signaling and sorting platforms of cells and their roles in cancer Expert Rev Proteom 8 2 2011 263 277
94. T.M. Williams, G.S. Hassan, J. Li, A.W. Cohen, F. Medina, and P.G. Frank Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice J Biol Chem 280 26 2005 25134 25145 (Pubitemid 40934606)
95. G. Papadopoulos, D. Delakas, L. Nakopoulou, and T. Kassimatis Statins and prostate cancer: molecular and clinical aspects Eur J Cancer 47 6 2011 819 830
96. S. Crnalic, E. Hornberg, P. Wikstrom, U.H. Lerner, A. Tieva, and O. Svensson Nuclear androgen receptor staining in bone metastases is related to a poor outcome in prostate cancer patients Endocr Relat Cancer 17 4 2010 885 895
97. E.A. Mostaghel, S.T. Page, D.W. Lin, L. Fazli, I.M. Coleman, and L.D. True Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer Cancer Res 67 10 2007 5033 5041 (Pubitemid 46910214)
98. C. Cai, S. Chen, P. Ng, G.J. Bubley, P.S. Nelson, and E.A. Mostaghel Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors Cancer Res 71 20 2011 6503 6513
99. C. Cai, and S.P. Balk Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy Endocr Relat Cancer 18 5 2011 R175 R182
100. E. Thysell, I. Surowiec, E. Hornberg, S. Crnalic, A. Widmark, and A.I. Johansson Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol PLoS ONE 5 12 2010 e14175
101. R.B. Montgomery, E.A. Mostaghel, R. Vessella, D.L. Hess, T.F. Kalhorn, and C.S. Higano Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth Cancer Res 68 11 2008 4447 4454
102. J.A. Locke, E.S. Guns, A.A. Lubik, H.H. Adomat, S.C. Hendy, and C.A. Wood Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer Cancer Res 68 15 2008 6407 6415
103. E.A. Mostaghel, K.R. Solomon, K. Pelton, M.R. Freeman, and R.B. Montgomery Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors PLoS ONE 7 1 2012 e30062
104. K. Brusselmans, E. De Schrijver, W. Heyns, G. Verhoeven, and J.V. Swinnen Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells Int J Cancer 106 6 2003 856 862 (Pubitemid 37071663)
105. H. Orita, J. Coulter, C. Lemmon, E. Tully, A. Vadlamudi, and S.M. Medghalchi Selective inhibition of fatty acid synthase for lung cancer treatment Clin Cancer Res 13 23 2007 7139 7145 (Pubitemid 350276900)
106. J.M. McFadden, S.M. Medghalchi, J.N. Thupari, M.L. Pinn, A. Vadlamudi, and K.I. Miller Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase J Med Chem 48 4 2005 946 961 (Pubitemid 40270441)
107. T.M. Loftus, D.E. Jaworsky, G.L. Frehywot, C.A. Townsend, G.V. Ronnett, and M.D. Lane Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors Science 288 5475 2000 2379 2381 (Pubitemid 30448165)
108. F.P. Kuhajda, E.S. Pizer, J.N. Li, N.S. Mani, G.L. Frehywot, and C.A. Townsend Synthesis and antitumor activity of an inhibitor of fatty acid synthase Proc Natl Acad Sci U S A 97 7 2000 3450 3454 (Pubitemid 30183323)
109. M.J. Vazquez, W. Leavens, R. Liu, B. Rodriguez, M. Read, and S. Richards Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the beta-ketoacyl reductase reaction FEBS J 275 7 2008 1556 1567 (Pubitemid 351388801)
110. T. Maier, M. Leibundgut, and N. Ban The crystal structure of a mammalian fatty acid synthase Science 321 5894 2008 1315 1322
111. E.K. Kim, I. Miller, S. Aja, L.E. Landree, M. Pinn, and J. McFadden C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase J Biol Chem 279 19 2004 19970 19976 (Pubitemid 38623439)
112. L.E. Landree, A.L. Hanlon, D.W. Strong, G. Rumbaugh, I.M. Miller, and J.N. Thupari C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism J Biol Chem 279 5 2004 3817 3827 (Pubitemid 38140627)
113. S. Braun, K. Bitton-Worms, and D. LeRoith The link between the metabolic syndrome and cancer Int J Biol Sci 7 7 2011 1003 1015
114. M.H. Faulds, and K. Dahlman-Wright Metabolic diseases and cancer risk Curr Opin Oncol 24 1 2012 58 61
115. H.A. Hirsch, D. Iliopoulos, A. Joshi, Y. Zhang, S.A. Jaeger, and M. Bulyk A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases Cancer Cell 17 4 2010 348 361
116. S. Jiralerspong, S.L. Palla, S.H. Giordano, F. Meric-Bernstam, C. Liedtke, and C.M. Barnett Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer J Clin Oncol 27 20 2009 3297 3302
117. N. Ruderman, and M. Prentki AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome Nat Rev Drug Discov 3 4 2004 340 351 (Pubitemid 38499761)
118. Z. Luo, A.K. Saha, X. Xiang, and N.B. Ruderman AMPK, the metabolic syndrome and cancer Trends Pharmacol Sci 26 2 2005 69 76 (Pubitemid 40170168)
119. B. Viollet, F. Andreelli, S.B. Jorgensen, C. Perrin, D. Flamez, and J. Mu Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models Biochem Soc Trans 31 Pt 1 2003 216 219 (Pubitemid 36241431)
120. G. Zadra, C. Priolo, A. Patnaik, and M. Loda New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK Clin Cancer Res 16 13 2010 3322 3328
121. R. Flavin, G. Zadra, and M. Loda Metabolic alterations and targeted therapies in prostate cancer J Pathol 223 2011 283 294
122. B.R. Pflug, S.M. Pecher, A.W. Brink, J.B. Nelson, and B.A. Foster Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model Prostate 57 3 2003 245 254 (Pubitemid 37267807)
123. X. Wu, M. Zayzafoon, X. Zhang, and O. Hameed Is there a role for fatty acid synthase in the diagnosis of prostatic adenocarcinoma?: A comparison with AMACR Am J Clin Pathol 136 2 2011 239 246
124. 18F]fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization J Med Chem 54 1 2011 406 410
125. 11C-acetate PET imaging of prostate cancer J Nucl Med 43 2 2002 181 186 (Pubitemid 34151040)
126. 18F-FDG in prostate cancer patients Eur J Nucl Med Mol Imaging 30 4 2003 607 611 (Pubitemid 36559841)
127. 11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer J Nucl Med 49 2 2008 327 334 (Pubitemid 351225673)
128. 11C-acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation J Nucl Med 53 4 2012 1 8
129. C. Rodriguez, S.J. Freedland, A. Deka, E.J. Jacobs, M.L. McCullough, and A.V. Patel Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol Biomarkers Prev 16 1 2007 63 69 (Pubitemid 46174265)
130. E. Giovannucci, Y. Liu, E.A. Platz, M.J. Stampfer, and W.C. Willett Risk factors for prostate cancer incidence and progression in the health professionals follow-up study Int J Cancer 121 7 2007 1571 1578 (Pubitemid 47328718)
131. S.J. Freedland Obesity and prostate cancer: a growing problem Clin Cancer Res 11 19 Pt 1 2005 6763 6766 (Pubitemid 41428728)
132. S. Narita, N. Tsuchiya, M. Saito, T. Inoue, T. Kumazawa, and T. Yuasa Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis Prostate 68 3 2008 321 335 (Pubitemid 351273061)
133. P. Mukherjee, A.V. Sotnikov, H.J. Mangian, J.R. Zhou, W.J. Visek, and S.K. Clinton Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression J Natl Cancer Inst 91 6 1999 512 523 (Pubitemid 29157059)
134. W.J. Aronson, R.J. Barnard, S.J. Freedland, S. Henning, D. Elashoff, and P.M. Jardack Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer J Urol 183 1 2010 345 350
135. S. Salem, M. Salahi, M. Mohseni, H. Ahmadi, A. Mehrsai, and Y. Jahani Major dietary factors and prostate cancer risk: a prospective multicenter case-control study Nutr Cancer 63 1 2011 21 27
136. G. Llaverias, C. Danilo, Y. Wang, A.K. Witkiewicz, K. Daumer, and M.P. Lisanti A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer Am J Pathol 177 6 2010 3180 3191
137. N. Kobayashi, R.J. Barnard, J. Said, J. Hong-Gonzalez, D.M. Corman, and M. Ku Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model Cancer Res 68 8 2008 3066 3073 (Pubitemid 351556309)
138. A. Lophatananon, J. Archer, D. Easton, R. Pocock, D. Dearnaley, and M. Guy Dietary fat and early-onset prostate cancer risk Br J Nutr 103 9 2010 1375 1380
139. S.J. Freedland, J. Mavropoulos, A. Wang, M. Darshan, W. Demark-Wahnefried, and W.J. Aronson Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis Prostate 68 1 2008 11 19
140. J.C. Lloyd, J.A. Antonelli, T.E. Phillips, E.M. Masko, J.A. Thomas, and S.H. Poulton Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model J Urol 183 4 2010 1619 1624
141. L.K. Dennis, L.G. Snetselaar, B.J. Smith, R.E. Stewart, and M.E. Robbins Problems with the assessment of dietary fat in prostate cancer studies Am J Epidemiol 160 5 2004 436 444 (Pubitemid 39166976)
142. J. Beare-Rogers, A. Dieffenbacher, and J.V. Holm Lexicon of lipid nutrition Pure Appl Chem 73 4 2001 685 744
143. S.S. Strom, Y. Yamamura, M.R. Forman, C.A. Pettaway, S.L. Barrera, and J. DiGiovanni Saturated fat intake predicts biochemical failure after prostatectomy Int J Cancer 122 11 2008 2581 2585 (Pubitemid 351590493)
144. S.Y. Park, L.R. Wilkens, S.M. Henning, L. Le Marchand, K. Gao, and M.T. Goodman Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort Cancer Causes Control 20 2 2009 211 223
145. A.S. Whittemore, L.N. Kolonel, A.H. Wu, E.M. John, R.P. Gallagher, and G.R. Howe Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada J Natl Cancer Inst 87 9 1995 652 661
146. M.D. Jackson, S.P. Walker, C.M. Simpson-Smith, C.M. Lindsay, G. Smith, and N. McFarlane-Anderson Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica Cancer Causes Control 23 1 2012 23 33
147. F.L. Crowe, T.J. Key, P.N. Appleby, R.C. Travis, K. Overvad, and M.U. Jakobsen Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition Am J Clin Nutr 87 5 2008 1405 1413 (Pubitemid 351679784)
148. N. Kurahashi, M. Inoue, M. Iwasaki, S. Sasazuki, and A.S. Tsugane Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men Cancer Epidemiol Biomarkers Prev 17 4 2008 930 937 (Pubitemid 351536425)
149. M. de Lourdes Arruzazabala, V. Molina, R. Mas, D. Carbajal, D. Marrero, and V. Gonzalez Effects of coconut oil on testosterone-induced prostatic hyperplasia in Sprague-Dawley rats J Pharm Pharmacol 59 7 2007 995 999 (Pubitemid 47051081)
150. E.L. Escobar, M.C. Gomes-Marcondes, and H.F. Carvalho Dietary fatty acid quality affects AR and PPARgamma levels and prostate growth Prostate 69 5 2009 548 558
151. K. Tamura, A. Makino, F. Hullin-Matsuda, T. Kobayashi, M. Furihata, and S. Chung Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism Cancer Res 69 20 2009 8133 8140
152. T. Naganuma, Y. Sato, T. Sassa, Y. Ohno, and A. Kihara Biochemical characterization of the very long-chain fatty acid elongase ELOVL7 FEBS Lett 585 20 2011 3337 3341
153. T.L. Romanuik, T. Ueda, N. Le, S. Haile, T.M. Yong, and T. Thomson Novel biomarkers for prostate cancer including noncoding transcripts Am J Pathol 175 6 2009 2264 2276
154. M.V. Chakravarthy, Y. Zhu, M. Lopez, L. Yin, D.F. Wozniak, and T. Coleman Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis J Clin Invest 117 9 2007 2539 2552 (Pubitemid 47494355)
155. M.V. Chakravarthy, Z. Pan, Y. Zhu, K. Tordjman, J.G. Schneider, and T. Coleman New hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis Cell Metab 1 5 2005 309 322 (Pubitemid 43977168)
156. A. Trichopoulou, P. Lagiou, H. Kuper, and D. Trichopoulos Cancer and Mediterranean dietary traditions Cancer Epidemiol Biomarkers Prev 9 9 2000 869 873
157. J. Lopez-Miranda, F. Perez-Jimenez, E. Ros, R. De Caterina, L. Badimon, and M.I. Covas Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008 Nutr Metab Cardiovasc Dis 20 4 2010 284 294
158. E. Bidoli, R. Talamini, C. Bosetti, E. Negri, D. Maruzzi, and M. Montella Macronutrients, fatty acids, cholesterol and prostate cancer risk Ann Oncol 16 1 2005 152 157 (Pubitemid 40124493)
159. V. Venkateswaran, and L.H. Klotz Diet and prostate cancer: mechanisms of action and implications for chemoprevention Nat Rev Urol 7 8 2010 442 453
160. I.M. Berquin, I.J. Edwards, S.J. Kridel, and Y.Q. Chen Polyunsaturated fatty acid metabolism in prostate cancer Cancer Metastasis Rev 30 3-4 2011 295 309
161. G.C. Burdge, and P.C. Calder Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults Reprod Nutr Dev 45 5 2005 581 597 (Pubitemid 41511883)
162. I.M. Berquin, I.J. Edwards, and Y.Q. Chen Multi-targeted therapy of cancer by omega-3 fatty acids Cancer Lett 269 2 2008 363 377
163. Y.Q. Chen, I.J. Edwards, S.J. Kridel, T. Thornburg, and I.M. Berquin Dietary fat-gene interactions in cancer Cancer Metastasis Rev 26 3-4 2007 535 551 (Pubitemid 350115105)
164. X. Wang, H. Lin, and Y. Gu Multiple roles of dihomo-gamma-linolenic acid against proliferation diseases Lipids Health Dis 11 1 2012 25
165. J.T. Bernert Jr., and H. Sprecher Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids Biochim Biophys Acta 398 3 1975 354 363
166. W. Zhang, B. Chakravarty, F. Zheng, Z. Gu, H. Wu, and J. Mao Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid Proc Natl Acad Sci U S A 108 38 2011 15757 15762
167. C.D. Williams, B.M. Whitley, C. Hoyo, D.J. Grant, J.D. Iraggi, and K.A. Newman A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer Nutr Res 31 1 2011 1 8
168. I.M. Berquin, Y. Min, R. Wu, J. Wu, D. Perry, and J.M. Cline Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids J Clin Invest 117 7 2007 1866 1875 (Pubitemid 47036320)
169. N. Kobayashi, R.J. Barnard, S.M. Henning, D. Elashoff, S.T. Reddy, and P. Cohen Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2 Clin Cancer Res 12 15 2006 4662 4670 (Pubitemid 44297819)
170. J.A. Akinsete, G. Ion, T.R. Witte, and W.E. Hardman Consumption of high omega-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice Carcinogenesis 33 1 2012 140 148